Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1613 | Thyroid (non-cancer) | ICEECE2012

Effect of combination therapy with potassium iodide and 15 mg of methimazole for Graves’ hyperthyroidism

Mashio Y. , Senshu N. , Beniko M. , Ikawa H. , Ikota A.

Introduction: Iodide administration is generally recommended in combination with anti-thyroid drugs when a rapid return to normal thyroid hormone levels is required, such as in the treatment of patients with ‘thyroid storm’. However, there are few reports concerning the combination therapy for many patients with Graves’ hyperthyroidism. In this paper, we studied the effects of potassium iodide (KI) combined with 15 mg of methimazole (MMI) to the initial treatmen...

ea0029p1634 | Thyroid (non-cancer) | ICEECE2012

Prediction of remission rate in the patients with Graves’ disease after treatment with a minimum maintenance dose of Methimazole

Beniko M. , Ikawa H. , Mori T. , Kudo H. , Matsumoto A. , Sekiguchi M. , Mashio Y.

Introduction: According to the guideline for medical treatment of Graves’ disease by the Japan Thyroid Association in 2011, discontinuation of antithyroid drug is recommended when normal thyroid functions have been maintained for a certain period (≥6 months) after treatment with a minimum maintenance dose (mentioned below). We prospectively studied the remission rates in the patients with Graves’ disease.Methods: The subjects were 108 pat...